✦ LIBER ✦

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma

✍ Scribed by Maruyama, R; Yamana, K; Itoi, T; Hara, N; Bilim, V; Nishiyama, T; Takahashi, K; Tomita, Y

Book ID: 109998944
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 189 KB
Volume: 95
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6603359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absence of Bcl-2 and Fas/CD95/APO-1 pred

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma

✍ Ornstein, D.K.; Finley, D.S. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 55 KB

Expression and prognostic relevance of t

Expression and prognostic relevance of the death receptor CD95 (Fas/APO1) in renal cell carcinomas

✍ Stephan Macher-Goeppinger; Justo Lorenzo Bermejo; Nina Wagener; Markus Hohenfell 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 791 KB

Novel Egr/NF-AT composite sites mediate

Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation

✍ Min Li-Weber; Oskar Laur; Peter H. Krammer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 2 views

Expression of the CD95 (APO-1/Fas) ligand (CD95L) in activated T cells is a major cause of activation-induced T cell apoptosis. The transcription factors NF-AT and Egr-3 (a member of the immediate-early transcription factors involved in cellular growth and differentiation) have been implicated in ac

Prediction of response to combined immun

Prediction of response to combined immunotherapy with interferon-α and low-dose interleukin-2 in metastatic renal cell carcinoma: Expression patterns of potential molecular markers in radical nephrectomy specimens

✍ Hideaki Miyake; Iori Sakai; Mototsugu Muramaki; Toshifumi Kurahashi; Atsushi Tak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

PREDICTION OF RESPONSE TO IMMUNOTHERAPY

PREDICTION OF RESPONSE TO IMMUNOTHERAPY WITH INTERFERON-α AND LOW-DOSE INTERLEUKIN-2 IN METASTATIC RENAL CELL CARCINOMA BASED ON EXPRESSION LEVELS OF POTENTIAL MOLECULAR MARKERS IN RADICAL NEPFRECTOMY SPECIMENS

✍ Muramaki, Mototsugu; Miyake, Hideaki; Takenaka, Atsushi; Kamidono, Sadao; Fujisa 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 132 KB